
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Peripheral immune characteristics of hepatitis B virus-related hepatocellular carcinoma
Ruonan Sun, Jiawei Li, Xianyi Lin, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 10
Ruonan Sun, Jiawei Li, Xianyi Lin, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 10
Showing 10 citing articles:
γδ T Cells: A Game Changer in the Future of Hepatocellular Carcinoma Immunotherapy
Stavros P. Papadakos, Konstantinos Arvanitakis, Ioanna Ε. Stergiou, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1381-1381
Open Access | Times Cited: 6
Stavros P. Papadakos, Konstantinos Arvanitakis, Ioanna Ε. Stergiou, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1381-1381
Open Access | Times Cited: 6
Study on the Prognostic Value of Peripheral Blood CD8+T Cells in Hepatocellular Carcinoma after Curative Hepatectomy
浩然 孙
Advances in Clinical Medicine (2025) Vol. 15, Iss. 01, pp. 507-516
Closed Access
浩然 孙
Advances in Clinical Medicine (2025) Vol. 15, Iss. 01, pp. 507-516
Closed Access
Immune Regulatory Networks and Therapy of γδ T Cells in Liver Cancer: Recent Trends and Advancements
Kun-Li Yin, Kai-Jian Chu, Ming O. Li, et al.
Journal of Clinical and Translational Hepatology (2024) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 4
Kun-Li Yin, Kai-Jian Chu, Ming O. Li, et al.
Journal of Clinical and Translational Hepatology (2024) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 4
Causal Effects and Immune Cell Mediators of Prescription Analgesic Use and Risk of Liver Cancer and Precancerosis in European Population: A Mendelian Randomization Study
Xuewen Tao, Shuai Mao, Jincheng Wang, et al.
Biomedicines (2024) Vol. 12, Iss. 7, pp. 1537-1537
Open Access | Times Cited: 1
Xuewen Tao, Shuai Mao, Jincheng Wang, et al.
Biomedicines (2024) Vol. 12, Iss. 7, pp. 1537-1537
Open Access | Times Cited: 1
Overexpression of tousled-like kinase 2 predicts poor prognosis in HBV-related hepatocellular carcinoma patients after radical resection
Bang Liu, Lingling Lu, Li Yu, et al.
Frontiers in Genetics (2024) Vol. 14
Open Access
Bang Liu, Lingling Lu, Li Yu, et al.
Frontiers in Genetics (2024) Vol. 14
Open Access
Causal Links Between Circulating Immune Traits and Hepatocellular Carcinoma: A Bi- Directional Mendelian Randomization Study
Xiaonan Xiang, Zhixiong Shi, Jianguo Wang, et al.
Research Square (Research Square) (2024)
Open Access
Xiaonan Xiang, Zhixiong Shi, Jianguo Wang, et al.
Research Square (Research Square) (2024)
Open Access
The Adaptive Immune Response in Hepatitis B Virus-Associated Hepatocellular Carcinoma Is Characterized by Dysfunctional and Exhausted HBV-Specific T Cells
Malene Broholm, Anne-Sofie Mathiasen, Ása Didriksen Apol, et al.
Viruses (2024) Vol. 16, Iss. 5, pp. 707-707
Open Access
Malene Broholm, Anne-Sofie Mathiasen, Ása Didriksen Apol, et al.
Viruses (2024) Vol. 16, Iss. 5, pp. 707-707
Open Access
Understanding lactate in the development of Hepatitis B virus-related hepatocellular carcinoma
Sheida Behzadi Sheikhrobat, Shahab Mahmoudvand, Salva Kazemipour-Khabbazi, et al.
Infectious Agents and Cancer (2024) Vol. 19, Iss. 1
Open Access
Sheida Behzadi Sheikhrobat, Shahab Mahmoudvand, Salva Kazemipour-Khabbazi, et al.
Infectious Agents and Cancer (2024) Vol. 19, Iss. 1
Open Access
Hepatocellular carcinoma in HBsAg seroclearance: clinical features, recurrence, and prognosis following curative hepatectomy
Wei Xu, Huai Gong, Bolun Li, et al.
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access
Wei Xu, Huai Gong, Bolun Li, et al.
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access
Safety and efficacy of 48-week pegylated interferon-α-2b therapy in patients with hepatitis B virus-related compensated liver cirrhosis: a pilot observational study
Zehong Wang, Xuanxuan Wang, Li Zhou, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access
Zehong Wang, Xuanxuan Wang, Li Zhou, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access